Cargando…
Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis
Tuberculosis is a leading cause of death in our country. Multidrug-resistant tuberculosis increases the morbidity and mortality due to severe manifestations and difficult and prolonged medications. Newer antitubercular drugs like delamanid have been approved by WHO in management of these cases, but...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894277/ https://www.ncbi.nlm.nih.gov/pubmed/36695263 http://dx.doi.org/10.4103/lungindia.lungindia_451_22 |